Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Collomp K, et al
doctor unless it is co-signed or re-written by a Canadian-licensed practitioner
Final thought Hengruis GLP-1 patent fuels a $100B race, but Indias Patents Act tools and generic prowess can counter IP barriers
doi: 10.1016/j.physbeh.2022.113967 Summary Keywords glucagon-like peptide-1 receptor agonists, psychiatric adverse events, disproportionality analyses, FAERS database, pharmacovigilance study Citation Chen W, Cai P, Zou W and Fu Z (2024) Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database
A real consultation
US$ 26.50
US$ 23.97
US$ 22.64
US$ 23.25
US$ 21.39
US$ 26.99
US$ 28.70
US$ 28.14
